Riboflavin-Responsive Glutaryl CoA Dehydrogenase Deficiency
December 2005
in “
Molecular Genetics and Metabolism
”
Studysummary This study reports that riboflavin may increase enzymatic activity in a GCDH-deficient patient with specific mutations, but doesn't fully normalize urinary organic acid levels.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on doi.org →